Pancreatic Cancer: Current and Emerging Treatment Options

Dear Colleagues,

This Special Issue aims to provide a comprehensive overview of the current and emerging treatment options for pancreatic cancer. Pancreatic cancer remains one of the most challenging malignancies, with limited treatment success and poor prognosis. Therefore, it is crucial to explore novel therapeutic approaches and advancements in the field.

This Special Issue welcomes the submission of original research articles, reviews, and clinical studies that focus on various aspects of pancreatic cancer treatment. We encourage submissions that highlight innovative strategies, novel drug developments, targeted therapies, immunotherapies, and precision medicine approaches.

To ensure the highest quality and relevance of the published articles, this Special Issue will not accept mini-reviews or case reports. Instead, we aim to present in-depth research findings, evidence-based analyses, and critical evaluations of therapeutic interventions for pancreatic cancer.

We invite researchers, clinicians, and experts in the field to contribute their valuable insights and share their latest findings. By bringing together a diverse range of perspectives, we hope to foster collaboration, stimulate further research, and ultimately improve the outcomes for patients with pancreatic cancer.

Dr. Eleonora Lai
Prof. Dr. Nicola Silvestris
Prof. Dr. Mario Scartozzi
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• pancreatic cancer
• treatment options
• emerging therapies
• precision medicine
• immunotherapy
• targeted therapy